What are the opportunities and challenges that the growing network of regional trade agreements (RTAs) presents for companies as they expand internationally? Complying with RTAs facilitate international business by lowering the barriers to the cross-border flow of goods and services. In 2010, 41% of U.S. goods were exported to a country with which the U.S. has signed a trade agreement. RTAs also bring with them complex preferential rules of origin with which companies must comply in order to fully access their benefits. Continue reading Complying with Regional Trade Agreements to Expand Your Markets.
Trend #1: Pharma emerging markets increase contributions to innovation
The growing importance of emerging markets can be no longer ignored, in terms of where the pharmaceutical industry is turning for growth and profitability. The increased spending power of these so-called pharmerging markets has meant that new pharma products need to be launched on a more global scale than ever before. It is expected that this year pharmerging markets will increasingly influence the global strategy for pharma. Continue reading Trending in Pharmaceutical Industry | Are you prepared?
The pharmaceutical industry is changing dramatically with new regulations, advances in technology and tighter revenues. As a result, pharma companies are looking for ways to decrease risk and increase efficiency, transparency and collaboration in the supply chain, all in an effort to help them exploit new opportunities and meet the challenges they encounter along the way. Regardless of the niche you may occupy in the industry, here are five pharmaceutical trends to keep in mind that are sure to affect pharma company operations and business success this year: Continue reading 5 Pharmaceutical trends that you can’t ignore | Exploit new opportunities
1: ‘Balancing Increased Transparency With Clear Guidelines To Avoid ‘Unblinding’ Studies
The next big trend for biotech innovation is transparency. The industry is gradually waking up to the reality that it is no longer tenable to routinely withhold the methods and results of clinical trials from doctors, researchers, and patients.
The AllTrials initiative pushes for the publication of results from all clinical trials on treatments currently being used, so doctors have all the information available about a treatment to understand its risks and benefits. You wouldn’t think we’d need the initiative here in the United States – since 2008, the FDA has required results of all trials be posted within a year of completion of the trial. Unfortunately, an audit published in 2012 showed that most didn’t comply. Continue reading Collaboration and Innovation that we can expect | Biotech and Biopharma fields
- Patients are getting increasingly Proactive
Convenience is a strong motivating force among patients. Successful device and software manufacturers should bear this in mind. Devices that maximize user-friendliness, accuracy and ease of use will inevitably fare better than apps/devices that fail to consider simplicity and elegance of design and interface.